Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome

doi:10.12998/wjcc.v12.i3.503

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2059)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-6) series.

Item

Count

PDF

107

WORD

HTML

1021

Figures (1-6)

179

Tables (1-6)

147

Sum=1466

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

424

Sum=496

Jan 26, 2024 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Jan 26, 2024; 12(3): 503-516
Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.503

Full Size Figure Download Figure

Figure 1 Simple algorithm shows the genetic testing in Angelman syndrome. ¹Blood samples were collected for methylation analysis and Fluorescence in situ hybridization analysis at the same time. AS: Angelman syndrome; UPD: Uniparental disomy; UBE3A: Ubiquitin-protein ligase E3A.

Citation: Manoubi W, Mahdouani M, Hmida D, Kdissa A, Rouissi A, Turki I, Gueddiche N, Soyah N, Saad A, Bouwkamp C, Elgersma Y, Mougou-Zerelli S, Gribaa M. Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome. World J Clin Cases 2024; 12(3): 503-516
URL: https://www.wjgnet.com/2307-8960/full/v12/i3/503.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i3.503